Press Release
<p>WIN A $10,000 EDUCATION FUND FOR YOUR MIRACLE CHILD</p>
<p><strong>Ferring Pharmaceuticals Announces 2005 My Little Miracle Essay Contest</strong> </p>
<table class="newsroom">
<tr>
<td valign="top" width="57"><p><b>Contact:</b></p></td>
<td width="20" valign="top"></td>
<td width="304">
<p>Kelly Laban<br>
Kovak-Likly Communications<br>
(203)762-8833 x15 or KLaban@KLCpr.com</p>
</td>
</tr>
</table>
<p>If you are a mom who has successfully given birth using Ferring
Pharmaceuticals’ infertility products, you can win a $10,000 education fund or
one of 11 other prizes to support your child’s future. To be eligible, all you
need to do is write a brief essay on your journey to achieve parenthood and its
impact on your life. </p>
<p>Ferring’s <b>My Little Miracle Essay Contest </b>is open to women who have been
successfully treated with BRAVELLE<sup>®</sup> (urofollitropin for injection, purified),
REPRONEX<sup>®</sup> (menotropins for injection, USP) or a combination of both. The contest
celebrates the miracles of their children’s births and continues Ferring’s
tradition of providing value to their patients by offering education funds for
the winners’ children. </p>
<p>Ferring is also awarding a $5,000 education fund for the runner up and 10
honorable mention winners will each receive $1,000. </p>
<p>Essays should not exceed 800 words, must be written in English, include the
entrant’s name, address, phone number and age, as well as the child(ren)’s name
and age(s) and be submitted with a contest application and labeled photo. Entries
must be postmarked by August 30, 2005. Winners will be announced at the 61st Annual
Meeting of the American Society for Reproductive Medicine, October 15 - 19,
2005, at the Palais de Congrès in Montreal, Quebec, Canada. </p>
<p>For more details and a contest application visit www.ferringfertility.com,
www.ferringusa.com or call (203) 762-8833 and ask for the My Little Miracle
Essay Contest representative. </p>
<p>BRAVELLE<sup>®</sup> (urofollitropin for injection, purified) and REPRONEX<sup>®</sup> (menotropins
for injection, USP), like all gonadotropins, are potent substances capable of
causing mild to severe adverse reactions, including OHSS (incidence of 6.0% and
3.5%, respectively), with or without pulmonary or vascular complications, in
women undergoing therapy for infertility. </p>
<p>Both treatments are marketed by Ferring Pharmaceuticals Inc., a world leader in
naturally occurring protein hormones. Only physicians thoroughly familiar with
infertility treatment, including the risk of multiple births and adverse
reactions, should prescribe these medications. Like other products for ovarian
stimulation, treatment with BRAVELLE<sup>®</sup> and/ or REPRONEX<sup>®</sup> may result in multiple
gestations. </p>
<p># # # </p>
EUFLEXXA (1% sodium hyaluronate) is used to relieve knee pain due to osteoarthritis. It is used in people who do not get enough relief from simple pain medications such as acetaminophen or from exercise and physical therapy.
Important Safety Information
You should not receive this product if you have had any previous allergic reaction to EUFLEXXA or hyaluronan products. You should not have an injection into the knee if you have a knee joint infection or if you have skin disease or infection around the injection site.
EUFLEXXA is only for injection into the knee performed by a qualified doctor. After you receive this injection you may need to avoid activities such as jogging, tennis, heavy lifting, or standing on your feet for a long time (more than one hour). The safety and effectiveness of repeat treatment cycles of EUFLEXXA have not been established. The safety and effectiveness of EUFLEXXA have not been shown in people under 18 years of age.
Side effects sometimes seen when EUFLEXXA is injected into the knee joint were pain, swelling, skin irritation, and tenderness and these were generally mild and did not last long.
Please see Full Prescribing Information.
Please see Important Information for Patients.
Patient Treatment Information
PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS WEB SITE.
This website is intended only for US residents.
Euflexxa® is a registered trademark of Ferring Pharmaceuticals Inc.
